Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0B3ZF
|
||||
Former ID |
DIB014452
|
||||
Drug Name |
ORM-12741
|
||||
Synonyms |
Alpha 2c adrenoceptor antagonist (neurological diseases), Orion; Alpha 2c adrenoceptor antagonist (psychiatric disorders), Orion
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Alzheimer disease [ICD9: 331; ICD10:G30] | Phase 2 | [525230] | ||
Company |
Orion Corp
|
||||
Structure |
Download2D MOL |
||||
Formula |
C18H23NO2
|
||||
Canonical SMILES |
CC1(CCCN2C1C3=C(CC2)C4=CC=CC=C4O3)COC
|
||||
InChI |
1S/C18H23NO2/c1-18(12-20-2)9-5-10-19-11-8-14-13-6-3-4-7-15(13)21-16(14)17(18)19/h3-4,6-7,17H,5,8-12H2,1-2H3/t17-,18-/m1/s1
|
||||
InChIKey |
OCUKPFWNSAAHRP-QZTJIDSGSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Alpha-2C adrenergic receptor | Target Info | Antagonist | [532654] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.